Table 1:

An organized table listing the various drugs used in pre-clinical and clinical studies discussed in the paper.

Drug Abreviation	Drug Full Name	Derivative	Specificity
AGONISTS
WIN 55212-2	WIN 55212-2	Synthetic	CB1R Full Agonist CB2R Full Agnoist
Indole	Indole	Synthetic	Peripherally restricted CB1R agonist
Indene	Indene	Synthetic	Peripherally restricted CB1R agonist
URB937	URB937	Synthetic	Peripherally restricted CB1R agonist
ZCZ011	ZCZ011	Synthetic	CB1R Allosteric Modulator
AZD1940	AZD1940	Synthetic	Peripherally restricted CB1R agonist
AZD1704	AZD1704	Synthetic	Peripherally restricted CB1R agonist
CP-55,940	CP-55,940	Synthetic	CB1R Full Agonist CB2R Full Agnoist
HU-210	HU-210	Synthetic	CB1R Full Agonist CB2R Full Agnoist
Δ 9-THC	Δ9-tetrahydrocannabinol	Plant-based Derivative	CB1R Full Agonist CB2R Full Agnoist
Anandamide	N-arachidonoylethanolamine	Endogenous	CB1R Partial Agonist CB2R Partial Agnoist
2-AG	2-arachidonoylglycerol	Endogenous	CB1R Full Agonist CB2R Partial Agnoist
ACEA	Arachidonyl-2-chloroethylamide	Endogenous	CB1R Full Agonist
ANTAGONISTS
ACPA	Arachidonylcyclopropylamide	Synthetic	CB1R Antagonist
SR141716	[3H]rimonabant	Synthetic	CB1R Antagonist
This table is meant to be a reference and assist the reader throughout the article of distingusihing important drug informaiton and how it pertains to the experimental results described.

Note. CB1R = cannabinoid receptor type 1; CB2R = cannabinoid receptor type 2.